The impact of margin status in breast-conserving therapy for lobular carcinoma is age related

European Journal of Surgical Oncology

Volumn 36, Issue 2, 2010, Pages 176-181

  Jobsen, J J ^a   Riemersma, S ^b   van der Palen, J ^c   Ong, F ^a   Jonkman, A ^a   Struikmans, H ^d  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

^b Laboratorium Pathologie Oost Nederland   (Netherlands)

^c UNIVERSITY OF TWENTE   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Age; Breast conserving therapy; Lobular carcinoma; Margin status; Outcome

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; BREAST CARCINOMA; BREAST CONSERVING THERAPY; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER INVASION; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CARCINOMA IN SITU; CLINICAL TRIAL; DISEASE FREE SURVIVAL; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MULTIMODALITY CANCER THERAPY; PREDICTION; PRIORITY JOURNAL; SURVIVAL RATE; TREATMENT OUTCOME; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, LOBULAR; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; SURVIVAL RATE;

EID: 74149083742     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2009.06.003     Document Type: Article

References (23)

1. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 (2002) 1233-1241
2. Veronesi U., Cascinelli N., Mariani L., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347 (2002) 1227-1232
3. Aprino G., Bardou V.J., Clark G.M., et al. Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome. Breast Cancer Res Treat 6 (2004) 149-155
4. Li C.I., Anderson B.O., Daling J.R., et al. Trends in incidence rates of invasive lobular and ductal breast carcinoma. J Am Med Assoc 289 (2003) 1421-1424
5. Singletary S.E., Patel-Parekh L., and Bland K.I. Treatment trends in early-stage invasive lobular carcinoma. A report from the national cancer data base. Ann Surg 242 (2005) 281-289
6. Møller Talman M.L., Jensen M.B., and Rank F. Invasive lobular breast cancer. Prognostic significance of histological malignancy grading. Acta Oncol 46 (2007) 803-809
7. Jobsen J.J., van der Palen J., Ong F., et al. Differences in outcome for positive margins in a large cohort of breast cancer patients treated with breast-conserving therapy. Acta Oncol 46 (2007) 172-180
8. Jobsen J.J., van der Palen J., Ong F., et al. The value of a positive margin for invasive carcinoma in breast conservative treatment in relation to local recurrence is limited to young women only. Int J Radiat Oncol Biol Phys 57 (2003) 724-731
9. Sastre-Garau X., Jouve M., Asselain B., et al. Infiltrating lobular carcinoma of the breast. Cancer 77 (1996) 113-120
10. Winchester D.J., Chang H.R., Graves T.A., et al. A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes. J Am Coll Surg 186 (1998) 416-422
11. Stata/SE 10.0 for Windows. Stata Press, College Station; Stata Corporation; 2007.
12. Bartelink H., Horiot J.C., Poortmans P.M., et al. Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial. J Clin Oncol 25 (2007) 3259-3265
13. Luini A., Rososchansky J., Gatti G., et al. The surgical margin status after breast-conserving surgery: discussion of an open issue. Breast Cancer Res Treat 113 (2009) 397-402
14. Von Smitten K. Margin status after breast-conserving treatment of breast cancer: how much free margin is enough?. J Surg Oncol 98 (2008) 585-587
15. Moore M.M., Borossa G., Imbrie J.Z., et al. Association of infiltrating lobular carcinoma with positive surgical margins after breast-conservative therapy. Ann Surg 231 (2000) 877-882
16. Salvadori B., Biganzoli E., Veronesi P., et al. Conservative surgery for infiltrating lobular breast carcinoma. Br J Surg 84 (1997) 106-109
17. Hussien M., Lioe T., Finnegan J., et al. Surgical treatment for invasive lobular carcinoma of the breast. Breast 12 (2003) 23-35
18. Rakha E.A., El-Sayed M.E., Powe D.G., et al. Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes. Eur J Cancer 44 (2008) 73-83
19. Silverstein M.J., Lewinsky B.S., Waisman J.R., et al. Infiltrating lobular carcinoma: is it different from infiltrating duct carcinoma?. Cancer 73 (1994) 1673-1677
20. Newman L.A., and Kuerer H.N. Advances in breast conservation therapy. J Clin Oncol 23 (2005) 1685-1697
21. Van den Broek N., van der Sangen M.J.C., van de Poll-Franse L.V., et al. Margin status and risk of local recurrence after breast-conserving treatment of lobular breast cancer. Breast Cancer Res Treat 105 (2007) 63-68
22. Pereira H., Pinder S.E., Sibbering D.M., et al. Pathological prognostic factors in breast cancer. IV: Should you be a typer or a grader? A comparative study of two histological prognostic features in operable breast carcinoma. Histopathology 27 (1995) 219-226
23. Sasson A.R., Fowble B., Hanlon A.L., et al. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with breast conservative surgery and radiation. Cancer 91 (2001) 1862-1869